This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Centre Hospitalier Universitaire De Nice, Centre National De La Recherche Scientifique. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2017
Title: The Innovative Contributions of Christophe Trojani
Introduction
Christophe Trojani is a notable inventor based in Falicon, France. He has made significant contributions to the field of biomaterials, particularly in the area of bone tissue regeneration. His innovative work has led to the development of a unique patent that combines blood with biphasic calcium phosphate ceramic particles.
Latest Patents
Trojani holds a patent for a biomaterial that contains coagulated blood or coagulated bone marrow aspirate along with biphasic calcium phosphate ceramic particles. This invention is crucial for producing implants that facilitate bone tissue regeneration. The combination of these materials enhances the effectiveness of the implants, making them a valuable asset in medical applications.
Career Highlights
Throughout his career, Christophe Trojani has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and the Centre Hospitalier Universitaire de Nice. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Trojani has collaborated with notable colleagues, including Thierry Balaguer and Nathalie Rochet. These partnerships have played a significant role in advancing his research and innovations in biomaterials.
Conclusion
Christophe Trojani's work exemplifies the impact of innovative thinking in the field of biomaterials. His patent for a unique combination of blood and ceramic particles showcases his commitment to advancing medical technology. Through his career and collaborations, Trojani continues to contribute to the important field of bone tissue regeneration.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile